LIGAND-INDUCED ADHESION TO ACTIVATED ENDOTHELIUM AND TO VASCULAR CELL-ADHESION MOLECULE-1 IN LYMPHOCYTES TRANSFECTED WITH THE N-FORMYL PEPTIDE RECEPTOR
S. Honda et al., LIGAND-INDUCED ADHESION TO ACTIVATED ENDOTHELIUM AND TO VASCULAR CELL-ADHESION MOLECULE-1 IN LYMPHOCYTES TRANSFECTED WITH THE N-FORMYL PEPTIDE RECEPTOR, The Journal of immunology, 152(8), 1994, pp. 4026-4035
Binding of FMLP to the neutrophil N-formyl peptide receptor (FPR) tran
smits signals through pertussis toxin-sensitive G proteins triggering
Ca2+ flux, superoxide production, granule exocytosis, and neutrophil a
ggregation and adhesion involving the beta 2 (CD18) integrins. Express
ion of the FPR in mouse fibroblasts or human kidney cells has been sho
wn to confer an N-formyl peptide-inducible Ca2+ flux in transfectants.
Here we demonstrate that the transfected receptor can also support li
gand-induced alterations in cellular adhesion. We established stable t
ransfectants of mouse L1-2 pre-B cells with cDNA for human FPR (L1-2 F
PR cells). The transfectants bind N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys-flu
orescein with 1.4 X 10(5) sites per cell and a dissociation constant o
f 3.3 nM. Stimulation with FMLP induces a transient Ca2+ flux. FMLP al
so triggers adhesion of L1-2 FPR cells to TNF-alpha- or LPS-activated
bEnd3 cells (mouse brain-derived endothelial cells) and to purified mo
use VCAM-1. Binding is inhibited by Abs to VCAM-1 and to the alpha-cha
in of its lymphocyte receptor (the alpha 4 beta 1 integrin, VLA-4). St
imulation with FMLP does not induce a change in cell surface expressio
n of alpha 4. Induced adhesion to VCAM-1 is rapid, detectable at the e
arliest times measurable (30 to 60 s after FMLP addition), and is inhi
bited by pertussis toxin. We conclude that FPR can mediate integrin ac
tivation not only in neutrophils but also in lymphocytes, and can trig
ger rapid adhesion via lymphocyte alpha 4 beta 1. The adhesion of lymp
hocytes is critical to their migration and targeting; our results sugg
est the possibility of manipulating adhesive responses through express
ion of chemoattractant receptors in lymphoid cells engineered for cell
ular therapy, allowing targeted adhesion and potentially migration in
response to locally administered ligands.